Sixfold Bioscience
YC W18 · Active · Delivering RNA therapies.
Competitors
| Company | Category | Status | Program |
|---|---|---|---|
| AI | Active | YCW22 | |
| AI | Active | YCS23 | |
| Other | Active | YCW18 | |
| Other | Active | YCW17 | |
| AI | Active | YCF25 |
Adjacent
| Company | Category | Status | Program |
|---|---|---|---|
| Other | Active | YCS18 | |
| Other | Active | YCW19 | |
| Other | Inactive | YCS18 | |
| Other | Active | YCW24 | |
| AI | Active | YCS25 |
Also from W18
All of W18About Sixfold Bioscience
Sixfold is focused on the commercialisation of its patented drug delivery systems for RNA therapeutics such as siRNAs for gene silencing and mRNAs for gene expression.
- YC batch
- W18 · Winter 2018
- Status, per YC
- Active
- Category
- Other
- Team size
- 27
- Location
- London, England, United Kingdom
- Checked
- 33m ago
YC tags: Gene Therapy, Nanomedicine, Drug Delivery
Sixfold Bioscience: questions
Which YC batch was Sixfold Bioscience in?
Sixfold Bioscience was in Y Combinator's Winter 2018 batch (W18).
Is Sixfold Bioscience still active?
Y Combinator lists Sixfold Bioscience as active.
Where is Sixfold Bioscience based?
Sixfold Bioscience lists London, England, United Kingdom as its location on YC's directory.
Sources: each program's public company list, read twice a week. Not affiliated with Y Combinator or any other program. Logos via logo.dev; trademarks belong to their owners.